Press Release Service
![Company](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_CMN_Companies_to_Follow_2023_01_17_81d7a58868_1c503a0f51.png)
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Metagenomi
Main focus: Next-generation gene-editing systems
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: CRISPR-Cas9, multiple undisclosed
Funding stage: Private
Location: Everyville, CA, USA
Website: https://metagenomi.co/
Partners: Moderna, Vor Biopharma
![](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_mg_wordmark_34517896ca_05b78839bb.png)
Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. The company has yet not disclosed any of its lead programmes, but announced a multi-year, multi-target collaboration with Moderna to develop in vivo gene-editing therapeutics.